ListedMainboardPRECPHARMA

Precision Pharma Ltd.

Precision Pharma Ltd. is a specialty pharmaceutical company focused on oncology and critical care therapeutics. The company has 15 approved products and a pipeline of 8 molecules under various stages of clinical trials.

Analyst Rating

Price Band

₹720 – ₹756

Lot Size

19 shares

Issue Size

₹907.2 Cr

Listing Price

₹890

About the Company

Sector

Pharmaceuticals

Founded

2010

Headquarters

Hyderabad, Telangana

Review Summary

Exceptional fundamentals with a strong product pipeline. High P/E but the oncology focus commands premium valuations. Strongly recommended.

Issue Details

Sale Type

Book Built

Issue Type

Fresh Issue + OFS

Face Value

₹2

Pre-Issue Holding

76%

Post-Issue Holding

58.4%

Listing At

BSE, NSE

Issue Breakdown

Fresh Issue

₹604.8 Cr

80,00,000 shares

Offer for Sale

₹302.4 Cr

40,00,000 shares

Timeline

Open Date

20 Jan 2026

Close Date

22 Jan 2026

Allotment Date

24 Jan 2026

Refund Date

25 Jan 2026

Credit Date

25 Jan 2026

Listing Date

27 Jan 2026

Financials

(₹ Lakhs)
YearAssetsRevenuePATNet Worth
FY20251,85,0001,42,00028,50078,000
FY20241,55,0001,12,00021,20055,000

Objects of Issue

R&D and clinical trials for pipeline molecules₹280.0 Cr
Expansion of manufacturing capacity₹180.0 Cr
Repayment of borrowings₹100.0 Cr
General corporate purposes₹44.8 Cr

GMP History

17 Jan 2026
+₹120

Est: ₹876

18 Jan 2026
+₹135

Est: ₹891

20 Jan 2026
+₹140

Est: ₹896

22 Jan 2026
+₹130

Est: ₹886

Subscription Status

20 Jan 2026

QIB: 1.2x
NII: 0.65x
Retail: 2.1x
Total: 1.38x

21 Jan 2026

QIB: 5.8x
NII: 3.45x
Retail: 6.2x
Total: 5.22x

22 Jan 2026

QIB: 28.5x
NII: 18.2x
Retail: 12.8x
Total: 19.83x

29,50,000 applications

Listing Performance

Listing Price₹890
Issue Price₹756
Listing Gain+17.72%
Current Price₹920
Current Gain+21.69%

Key Metrics

P/E Ratio

31.8x

ROE

36.5%

EPS

₹23.75

P/BV

9.7x

Market Cap

₹9072.0 Cr

IPO Team

Registrar

Link Intime India Pvt Ltd

Lead Managers

Morgan Stanley India, Goldman Sachs India